Published in Plant Mol Biol on November 01, 1993
Catalase is encoded by a multigene family in Arabidopsis thaliana (L.) Heynh. Plant Physiol (1996) 1.33
Identification of an Arabidopsis thaliana ribulose-1,5-bisphosphate carboxylase/oxygenase activase (RCA) minimal promoter regulated by light and the circadian clock. Plant Physiol (1996) 1.03
Expression quantitative trait loci analysis of two genes encoding rubisco activase in soybean. Plant Physiol (2009) 0.99
A clock- and light-regulated gene that links the circadian oscillator to LHCB gene expression. Plant Cell (2001) 0.91
Natural variation reveals that intracellular distribution of ELF3 protein is associated with function in the circadian clock. Elife (2014) 0.90
Changes at the 3'-untranslated region stabilize Rubisco activase transcript levels during heat stress in Arabidopsis. Planta (2012) 0.84
Symbiotic root nodules of the actinorhizal plant Datisca glomerata express Rubisco activase mRNA. Plant Physiol (1999) 0.83
Characterization of Rubisco activase genes in maize: an α-isoform gene functions alongside a β-isoform gene. Plant Physiol (2014) 0.80
Fairy "tails": flexibility and function of intrinsically disordered extensions in the photosynthetic world. Front Mol Biosci (2015) 0.79
The peach (Prunus persica [L.] Batsch) homeobox gene KNOPE3, which encodes a class 2 knotted-like transcription factor, is regulated during leaf development and triggered by sugars. Mol Genet Genomics (2009) 0.78
Depth-specific fluctuations of gene expression and protein abundance modulate the photophysiology in the seagrass Posidonia oceanica. Sci Rep (2017) 0.78
Identification of Two bZIP Transcription Factors Interacting with the Promoter of Soybean Rubisco Activase Gene (GmRCAα). Front Plant Sci (2016) 0.75
Purification of the DNA polymerase of avian myeloblastosis virus. Biochim Biophys Acta (1971) 6.64
Characterization of the products of DNA-directed DNA polymerases in oncogenic RNA viruses. Nature (1970) 5.23
DNA-directed DNA polymerase activity in oncogenic RNA viruses. Nature (1970) 4.81
Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science (1986) 4.04
Synthetic DNA-RNA hybrids and RNA-RNA duplexes as templates for the polymerases of the oncogenic RNA viruses. Nature (1970) 3.98
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50
HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J (1999) 3.10
The gag and pol genes of bovine leukemia virus: nucleotide sequence and analysis. Virology (1985) 2.53
Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics (1996) 2.34
[Isolation of messenger RNA from rabbit reticulocytes]. Biochim Biophys Acta (1965) 2.25
The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (1988) 2.16
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci U S A (1982) 2.02
Bovine leukemia virus: an exogenous RNA oncogenic virus. Proc Natl Acad Sci U S A (1976) 2.01
The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology (1984) 1.98
Class IIa histone deacetylases: regulating the regulators. Oncogene (2007) 1.78
In vivo infection of sheep by bovine leukemia virus mutants. J Virol (1993) 1.69
Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci U S A (1998) 1.68
DNA polymerase activities in varions of visna virus, a causative agent of a "slow" neurological disease. Proc Natl Acad Sci U S A (1971) 1.67
Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells. Science (1985) 1.67
Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51. J Virol Methods (1989) 1.66
Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. J Hum Virol (1999) 1.65
Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci U S A (1980) 1.61
Translation of bovine leukemia virus virion RNAs in heterologous protein-synthesizing systems. J Virol (1979) 1.60
Experiments with cloned complete tumor-derived bovine leukemia virus information prove that the virus is totally exogenous to its target animal species. J Virol (1981) 1.58
Isolation and characterization of a 2.3-kilobase-pair cDNA fragment encoding the binding domain of the bovine leukemia virus cell receptor. J Virol (1993) 1.58
C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci U S A (1998) 1.57
An immunophilin that binds M(r) 90,000 heat shock protein: main structural features of a mammalian p59 protein. Proc Natl Acad Sci U S A (1992) 1.56
Characterization of the messenger ribonucleoprotein released from reticulocyte polyribosomes by EDTA treatment. Eur J Biochem (1971) 1.56
Genomic integration of bovine leukemia provirus and lack of viral RNA expression in the target cells of cattle with different responses to BLV infection. Leuk Res (1980) 1.53
Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles. Virology (1993) 1.52
Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes. Proc Natl Acad Sci U S A (1975) 1.51
The bovine leukemia virus p34 is a transactivator protein. EMBO J (1987) 1.48
Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J (1990) 1.44
Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci U S A (2000) 1.42
Isolation of the mouse mammary tumor virus sequences not transmitted as germinal provirus in the C3H and RIII mouse strains. J Virol (1977) 1.39
Bovine leukemia virus, an animal model for the study of intrastrain variability. J Virol (1993) 1.38
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients. J Hum Virol (1999) 1.38
Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J (2008) 1.35
Release of messenger RNA from rabbit reticulocyte polyribosomes at low concentration of divalent cations. Biochim Biophys Acta (1967) 1.35
Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc Natl Acad Sci U S A (1994) 1.31
Mutations located on both F1 and F2 subunits of the Newcastle disease virus fusion protein confer resistance to neutralization with monoclonal antibodies. J Virol (1989) 1.30
Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol Cell Biol (1998) 1.30
Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Cancer Surv (1987) 1.29
Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J Virol (1990) 1.29
Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Vaccine (1991) 1.28
The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-kappaB proteins. J Virol (1997) 1.28
A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol (1994) 1.26
In vivo transfection of bovine leukemia provirus into sheep. Virology (1992) 1.25
Humoral antibody response to bovine leukemia virus infection in cattle and sheep. Cancer Res (1979) 1.24
Thermosensitive mutations affecting ribonucleic acid polymerases in Saccharomyces cerevisiae. J Bacteriol (1976) 1.24
Restriction endonuclease mapping of linear unintegrated proviral DNA of bovine leukemia virus. J Virol (1981) 1.24
Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer. Vet Microbiol (1988) 1.23
Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci U S A (1979) 1.23
Goat lymphosarcoma from bovine leukemia virus. J Natl Cancer Inst (1981) 1.22
Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study). J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.20
Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. Eur Respir J (1999) 1.20
Even transcriptionally competent proviruses are silent in bovine leukemia virus-induced sheep tumor cells. Proc Natl Acad Sci U S A (1988) 1.19
The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads. J Virol (1995) 1.18
Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res Hum Retroviruses (2000) 1.16
Separation of the messenger RNA of reticulocyte polyribosomes. Biochem Biophys Res Commun (1964) 1.16
Chromosome integration domain for bovine leukemia provirus in tumors. J Virol (1983) 1.16
Fusogenic segments of bovine leukemia virus and simian immunodeficiency virus are interchangeable and mediate fusion by means of oblique insertion in the lipid bilayer of their target cells. Proc Natl Acad Sci U S A (1992) 1.16
A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of the bovine leukemia virus long terminal repeat. J Virol (1992) 1.15
Bovine leukemia virus. Curr Top Microbiol Immunol (1984) 1.15
Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J Virol (1992) 1.14
In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J Virol (1998) 1.14
Role of the 3' long open reading frame region of bovine leukemia virus in the maintenance of cell transformation. J Virol (1985) 1.13
Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins. Biochim Biophys Acta (1990) 1.12
Bovine leukemia virus involvement in enzootic bovine leukosis. Adv Cancer Res (1978) 1.12
Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis. J Virol (1997) 1.11
Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS (1992) 1.11